About this trial
The purpose of this study is to explore a new way to examine the function of the muscles using a technique called high-resolution manometry. The study will enroll 30 adults with OSA, all of whom will use the myofunctional therapy (MFT) devices for 3 months. High-resolution manometry will be used to measure the amount of pressure generated by the muscles of the throat when drinking water or breathing air, both with and without the MFT devices, and before and after the MFT intervention. If successful, this method can help us understand why sleep improves after MFT.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 18-65
New diagnosis of OSA (AHI ≥ 5) or failure of first-line OSA treatment
Willingness to forego first-line OSA treatment or stop current OSA treatment for 3 months
Disqualifiers
Medical comorbidities that require restricting fluid intake (e.g., dysphagia, renal disease, liver disease, hyponatremia)
Severe nasal obstruction
Severe ankyloglossia
Craniofacial abnormality
Trial design
Single group
Treatments tested in this trial
Myofunctional Therapy
Procedure/SurgeryThe intervention consists of 90 days of MFT (5-6 days/week) along with completing daily logs. MFT will include high-intensity swallowing exercises and respiratory muscle strength training.
Treatment groups
Trial outcomes
Primary outcomes
MFT treatment fidelity
Treatment fidelity of two common MFTs (high-intensity swallowing exercises, respiratory muscle strength training) in individuals with OSA. Treatment fidelity will be determined via measuring the percent of sessions completed relative to the targeted number of sessions.
Pressure generation in posterior upper airway musculature
Comparison of pressure generation in posterior upper airway musculature before and after MFT intervention as assessed with HRM
Sponsors and contacts
Click on the lead sponsor to view all of their trials.